Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.320
+0.130 (10.92%)
At close: Nov 19, 2024, 4:00 PM
1.300
-0.020 (-1.51%)
After-hours: Nov 19, 2024, 5:56 PM EST
Bone Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 2 | 3 | 36 | 230 | 123 | |
| Market Cap Growth | 100.66% | -24.75% | -91.19% | -84.17% | 87.50% | -69.09% | |
| Enterprise Value | -1 | -2 | -2 | 49 | 241 | 134 | |
| Last Close Price | 1.32 | 4.52 | 50.33 | 844.80 | 4500.00 | 2400.00 | |
| PB Ratio | 0.73 | 0.83 | 0.54 | 5.54 | -16.81 | -10.34 | |
| P/TBV Ratio | 1.18 | 0.83 | 0.54 | 5.54 | - | - | |
| Debt / Equity Ratio | - | - | - | - | -0.86 | -0.95 | |
| Quick Ratio | 13.04 | 3.64 | 2.96 | 66.81 | - | 0.04 | |
| Current Ratio | 14.87 | 4.50 | 3.33 | 66.81 | - | 0.05 | |
| Return on Equity (ROE) | -109.17% | -202.15% | -23.71% | - | - | - | |
| Return on Assets (ROA) | -52.87% | -96.34% | -30.20% | - | - | -285.50% | |
| Return on Capital (ROIC) | -63.02% | -133.11% | -36.59% | -29.94% | - | - | |
| Earnings Yield | -149.60% | -370.62% | -46.27% | -4.42% | -0.79% | -2.79% | |
| FCF Yield | -173.05% | -395.77% | -111.16% | -3.37% | -0.19% | -2.65% | |
| Buyback Yield / Dilution | -518.58% | -452.14% | -10.51% | 15.67% | - | - | |
| Total Shareholder Return | -518.58% | -452.14% | -10.51% | 15.67% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.